Inventor

LEVY YVES

FR19 patents

⚠️ This page may combine multiple inventors who share the name “LEVY YVES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LEVY YVES

INST NAT SANTE RECH MED

Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity

Methods and compositions for treating and preventing HIV

Methods and compositions for treating and preventing HIV

Methods and compositions for treating and preventing HIV

Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity

Recombinant proteins with CD40 activating properties

P2X7 receptor antagonists for restoring T-cell lymphopoiesis in subjects infected with human immunodeficiency virus (HIV)

Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections

ZURAWSKI GERARD

Anti-CD40 targeted fusion proteins

Fusion protein with HIV antigen

Antigen presenting cell targeted anti-viral vaccines

BAYLOR RES INSTITUTE

Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides

Compositions and methods to immunize against hepatitis C virus

ANVAR

Method and device for converting thermal images into secondary images, e. g. visible images

BANCHEREAU JACQUES F

Dendritic cell vaccines

INST OPTIQUE THEORIQUE ET APPL

Method for characterizing a surface, and device therefor

COMMISSARIAT ENERGIE ATOMIQUE

Method for fixing a protein on a pyrrole-based polymer and use thereof for making a sensor

LEVY YVES

Synthetic gene construct coding for an HIV1 GAG and use thereof for obtaining anti-HIV-1 vaccines

INST NAT DE LA SANTE ET DE LA RECH MEDICALE (INSERM)

Soluble ST2 as a marker for risk of mortality in HIV-infected subjects